Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
- (-) Isotope Science and Enrichment Directorate (6)
Researcher
- Ali Passian
- Mike Zach
- Sergiy Kalnaus
- Andrew F May
- Ben Garrison
- Beth L Armstrong
- Brad Johnson
- Bruce Moyer
- Charlie Cook
- Christopher Hershey
- Claire Marvinney
- Craig Blue
- Daniel Rasmussen
- Debjani Pal
- Georgios Polyzos
- Harper Jordan
- Hsin Wang
- James Klett
- Jaswinder Sharma
- Jeffrey Einkauf
- Jennifer M Pyles
- Joel Asiamah
- Joel Dawson
- John Lindahl
- Justin Griswold
- Kuntal De
- Laetitia H Delmau
- Luke Sadergaski
- Nance Ericson
- Nancy Dudney
- Nedim Cinbiz
- Padhraic L Mulligan
- Sandra Davern
- Srikanth Yoginath
- Tony Beard
- Varisara Tansakul

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

We developed and incorporated two innovative mPET/Cu and mPET/Al foils as current collectors in LIBs to enhance cell energy density under XFC conditions.

The technologies provide a system and method of needling of veiled AS4 fabric tape.

The co-processing of cathode and composite electrolyte for solid state polymer batteries has been developed. A traditional uncalendared cathode of e.g.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

ORNL will develop an advanced high-performing RTG using a novel radioisotope heat source.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.